Citadel Advisors’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,568
| Closed | -$103K | – | 7375 |
|
|
2021
Q1 | $103K | Buy |
+1,568
| New | +$103K | ﹤0.01% | 5842 |
|
|
2020
Q4 | – | Sell |
-744
| Closed | -$44K | – | 5796 |
|
|
2020
Q3 | $44K | Buy |
744
+403
| +118% | +$23.8K | ﹤0.01% | 4419 |
|
|
2020
Q2 | $44K | Buy |
+341
| New | +$44K | ﹤0.01% | 4402 |
|
|
2019
Q4 | – | Sell |
-131
| Closed | -$16K | – | 5291 |
|
|
2019
Q3 | $16K | Sell |
131
-83
| -39% | -$10.1K | ﹤0.01% | 4546 |
|
|
2019
Q2 | $64K | Buy |
214
+130
| +155% | +$38.9K | ﹤0.01% | 4322 |
|
|
2019
Q1 | $38K | Sell |
84
-387
| -82% | -$175K | ﹤0.01% | 4301 |
|
|
2018
Q4 | $216K | Buy |
+471
| New | +$216K | ﹤0.01% | 3807 |
|
|
2018
Q3 | – | Sell |
-88
| Closed | -$52K | – | 4873 |
|
|
2018
Q2 | $52K | Sell |
88
-61
| -41% | -$36K | ﹤0.01% | 3908 |
|
|
2018
Q1 | $97K | Buy |
+149
| New | +$97K | ﹤0.01% | 3639 |
|
|
2016
Q4 | – | Sell |
-59
| Closed | -$25K | – | 4260 |
|
|
2016
Q3 | $25K | Buy |
+59
| New | +$25K | ﹤0.01% | 3384 |
|